Overview
- 4 public-safe observations are available for this inspection.
- 4 structured CFR citations are represented.
- 2 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
22 Jun 2011
21 CFR 314.80(b)
Failure to develop written procedures
Cited by Frederick Razzaghi, Dorothy J Denes
22 Jun 2011
21 CFR 314.80(c)(1)(i)
Late submission of 15-day report
Cited by Frederick Razzaghi, Dorothy J Denes
22 Jun 2011
21 CFR 314.80(c)(1)(ii)
Submission of report follow-up
Cited by Frederick Razzaghi, Dorothy J Denes
22 Jun 2011
21 CFR 314.80(c)(2)(ii)(A)
Incomplete periodic safety report
Cited by Frederick Razzaghi, Dorothy J Denes
Inspected site
RIRanbaxy Inc.Princeton, United States
Inspection team
DJDorothy J Denes
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 314.80(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 314.80(c)(1)(i) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 314.80(c)(1)(ii) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 314.80(c)(2)(ii)(A) | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 4 observations
Every observation in full, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere